Summit Therapeutics
SMMT
#1212
Rank
NZ$26.22 B
Marketcap
$35.55
Share price
-1.36%
Change (1 day)
414.51%
Change (1 year)

Revenue for Summit Therapeutics (SMMT)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Summit Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A-100%
2022 NZ$1.11 M-58.07%
2021 NZ$2.64 M
2019 NZ$2.14 M-98.13%
2018 NZ$0.11 B230.01%
2017 NZ$34.81 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$3.32 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.65 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.53 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA